Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Activator of G-protein signaling 8 (AGS8), also known as FNDC1, is a receptor-independent accessory protein that modulates heterotrimeric G protein signaling by directly interacting with the Gβγ subunit. AGS8 is upregulated in response to hypoxic or ischemic stress, particularly in cardiovascular tissues. It regulates cell survival and angiogenesis.
AGS8 modulates heterotrimeric G protein signaling by directly interacting with the Gβγ subunit, influencing downstream signaling pathways without requiring nucleotide exchange on the α-subunit.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Activator of G-protein signaling 8 (AGS8).